Buprenorphine and Integrated HIV Care Evaluation

Summary

The purpose of this study is to assess the feasibility, cost and effectiveness of interventions designed to integrate buprenorphine treatment for opioid dependence into HIV primary care in ten HIV care centers in the U.S.

Conditions

• Opioid-Related Disorders
• HIV Infections
• AIDS

Interventions

DRUG

Buprenorphine

BEHAVIORAL

Integrated HIV care and office-based opioid dependence treatment

Sponsors & Collaborators

• Health Resources and Services Administration (HRSA)

  collaborator FED

• El Rio Santa Cruz Neighborhood Health Center

  collaborator UNKNOWN

• Organization to Achieve Solutions in Substance Abuse (OASIS)

  collaborator OTHER

• Oregon Health and Science University

  collaborator OTHER

• Montefiore Medical Center

  collaborator OTHER

• University of Miami

  collaborator OTHER

• Brown University

  collaborator OTHER

• University of California, San Francisco

  collaborator OTHER

• Johns Hopkins University

  collaborator OTHER

• CORE Center, Cook County Bureau of Health Services

  collaborator UNKNOWN

• Yale University

  collaborator OTHER

• The New York Academy of Medicine

  lead OTHER

Principal Investigators

• Ruth Finkelstein, ScD · New York Academy of Medicine

• David Fiellin, MD · Yale University

Study Design

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2005-08-31

Completion

2008-12-31

Countries

• United States

Study Locations